Authors:
RAVAUD A
CHEVREAU C
CANY L
HOUYAU P
DOHOLLOU N
ROCHE H
SOUBEYRAN P
BONICHON F
MIHURA J
EGHBALI H
TABAH I
BUI BN
Citation: A. Ravaud et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR IN PATIENTS WITH NEUTROPENIC FEVER IS POTENT AFTER LOW-RISK BUT NOT AFTER HIGH-RISK NEUTROPENIC CHEMOTHERAPY REGIMENS - RESULTS OF A RANDOMIZED PHASE-III TRIAL, Journal of clinical oncology, 16(9), 1998, pp. 2930-2936
Authors:
DOMBRET H
SAELAND S
ROUSSELOT P
CHAIBI P
DANIEL MT
GARDIN C
HUNAULT M
ZINI JM
TAKSIN AL
BONNAL C
DOSQUET C
TABAH I
Citation: H. Dombret et al., INTERLEUKIN-4 (IL-4) THERAPY IN REFRACTORY OR RELAPSING ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A PHASE I-II STUDY, British Journal of Haematology, 102(1), 1998, pp. 89-89
Authors:
BRICE P
BASTION Y
LEPAGE E
BROUSSE N
HAIOUN C
MOREAU P
STRAETMANS N
TILLY H
TABAH I
SOLALCELIGNY P
Citation: P. Brice et al., COMPARISON IN LOW-TUMOR-BURDEN FOLLICULAR LYMPHOMAS BETWEEN AN INITIAL NO-TREATMENT POLICY, PREDNIMUSTINE, OR INTERFERON-ALFA - A RANDOMIZED STUDY FROM THE GROUPE-DETUDE-DES-LYMPHOMES-FOLLICULAIRES, Journal of clinical oncology, 15(3), 1997, pp. 1110-1117
Authors:
CADIOT G
ROUGIER P
CHAYVIALLE JA
DALMAGNESERRANO H
CHAUFFERT B
FOUCHARD I
CHAUSSADE S
TABAH I
MIGNON M
Citation: G. Cadiot et al., PHASE-II TREATMENT WITH DOXORUBICIN-STREPTOZOTOCIN AND INTRONA OF EVOLUTIVE LIVER METASTASES (LM) IN PATIENTS WITH ZOLLINGER-ELLISON-SYNDROME (ZES), Gastroenterology, 112(4), 1997, pp. 431-431
Authors:
COLOMBAT P
DELAIN M
DESBOIS I
DOMENECH J
BINET C
TABAH I
LAMAGNERE JP
LINASSIER C
Citation: P. Colombat et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR ACCELERATES HEMATOPOIETIC RECOVERY AFTER AUTOLOGOUS BONE-MARROW OR PERIPHERAL-BLOOD PROGENITOR-CELL TRANSPLANTATION AND HIGH-DOSE CHEMOTHERAPY FOR LYMPHOMA, Bone marrow transplantation, 18(2), 1996, pp. 293-299
Authors:
NEGRIER S
MERCATELLO A
BRET M
MERROUCHE Y
CORONEL B
FAVROT M
GASPARD M
DOREZ D
PHILIP I
LANIER F
THIESSE P
OSKAM R
PALMER P
TABAH I
MOSKOVTCHENKO JF
PHILIP T
Citation: S. Negrier et al., INTENSIVE REGIMEN OF CYTOKINES WITH INTERLEUKIN-2 AND INTERFERON ALFA-2B IN SELECTED PATIENTS WITH METASTATIC RENAL-CARCINOMA, Journal of immunotherapy with emphasis on tumor immunology, 17(1), 1995, pp. 62-68
Authors:
RAVAUD A
CHEVREAU C
BONICHON F
MIHURA J
BUI BN
TABAH I
Citation: A. Ravaud et al., A PHASE-III TRIAL OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) AS CORRECTIVE TREATMENT IN PATIENTS (PTS) WITH NEUTROPENIC FEVER FOLLOWING ANTINEOPLASTIC CHEMOTHERAPY (CT) - RESULTS OF AN INTERMEDIATE ANALYSIS, European journal of cancer, 31A, 1995, pp. 247-247
Authors:
TROUSSARD X
MACRO M
VIE B
BATHO A
PENY AM
REMAN O
TABAH I
LEPOR M
Citation: X. Troussard et al., HUMAN RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (HRGM-CSF) IMPROVES DOUBLE HEMIBODY IRRADIATION (DHBI) TOLERANCE IN PATIENTS WITH STAGE-III MULTIPLE-MYELOMA - A PILOT-STUDY, British Journal of Haematology, 89(1), 1995, pp. 191-195
Authors:
SEBBAN C
DELANNOY A
TABAH I
CONYMAKHOUN P
CAZIN B
CORDONNIER C
BOUABDALLAH R
CAHN JY
DREYFUS F
SADOUN A
GAY C
BROUSTET A
MICHAUX JL
FIERE D
Citation: C. Sebban et al., TREATMENT OF ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) IN THE ELDERLY - A FEASIBILITY STUDY OF INTERFERON DURING MAINTENANCE, Blood, 86(10), 1995, pp. 3105-3105
Authors:
FERME C
BRICE P
GABARRE J
DIVINE M
DETOURMIGNIES L
JAUBERT J
CAILLOT D
BASTION Y
ASSOULINE D
NEDELLEC G
ISNARD F
TABAH I
Citation: C. Ferme et al., MINE CHEMOTHERAPY PLUS RHGM-CSF AS SALVAGE AND PERIPHERAL-BLOOD PROGENITOR CELLS MOBILIZING REGIMEN FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE (HD), Blood, 84(10), 1994, pp. 10000162-10000162
Authors:
PHILIP T
NEGRIER S
LASSET C
CORONEL B
BRET M
BLAY JY
MERROUCHE Y
CARRIE C
KAEMMERLEN P
CHAUVIN F
FAVROT M
OSKAM R
TABAH I
CLAVEL M
MOSKOVTCHENKO JF
MERCATELLO A
Citation: T. Philip et al., PATIENTS WITH METASTATIC RENAL-CARCINOMA CANDIDATE FOR IMMUNOTHERAPY WITH CYTOKINES - ANALYSIS OF A SINGLE INSTITUTION STUDY ON 181 PATIENTS, British Journal of Cancer, 68(5), 1993, pp. 1036-1042